Related Experiment Video

Updated: Jun 8, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

154

Targeting Noncoding cis-Regulatory Elements for Cancer Therapy in the Context of the 3D Genome

Kailong Li1, Gong-Hong Wei2,3, Yuxin Yin4,5

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Cancer Discovery
|November 1, 2024
PubMed

Insights

Noncoding cis-regulatory elements, crucial for genome 3D organization, are emerging as novel therapeutic targets in cancer therapy. Further research into these elements and their alterations could lead to new treatment strategies.

Area of Science:

  • Genomics
  • Cancer Biology
  • Epigenetics

Background:

  • Oncoproteins and noncoding RNAs (ncRNAs) are established cancer therapeutic targets.
  • Noncoding cis-regulatory elements control genome 3D organization and gene expression.
  • These elements are increasingly recognized for their potential in cancer therapy.

Purpose of the Study:

  • To highlight noncoding cis-regulatory elements as potential therapeutic targets in cancer.
  • To emphasize the importance of understanding the noncoding cis-regulatory code.
  • To advocate for systematic surveys of functional elements and 3D genome alterations in tumors.

Main Methods:

  • This commentary discusses current understanding and future directions.
  • It proposes deciphering the noncoding cis-regulatory code.
  • It suggests systematic surveys of functional noncoding cis-regulatory elements and 3D genome alterations.

Main Results:

  • Emerging observations suggest noncoding cis-regulatory elements are viable therapeutic targets.
  • Understanding these elements can reveal novel therapeutic strategies.
  • Analyzing both cancerous and nonmalignant cells within tumors is crucial.

Conclusions:

  • Noncoding cis-regulatory elements offer a new frontier for cancer therapy development.
  • Deciphering the noncoding cis-regulatory code is essential for therapeutic innovation.
  • Systematic investigation of these elements and their genomic alterations will drive novel therapeutic strategies.

More Related Videos

Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations11:36

Author Spotlight: An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations

Published on: April 21, 2023

2.0K
HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

8.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

3.0K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K